Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dipexium Pharmaceuticals Inc (NASDAQ:DPRX)

15.53
Delayed Data
As of Sep 23
 +0.03 / +0.19%
Today’s Change
6.04
Today|||52-Week Range
16.32
+38.66%
Year-to-Date
No recent news for Dipexium Pharmaceuticals Inc.

Today’s Trading

Previous close15.50
Today’s open15.50
Day’s range15.31 - 16.00
Volume32,523
Average volume (3 months)33,094
Market cap$161.5M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-15.03%
Earnings growth (this year)-5.53%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.19

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...+0.07+0.79%
SYNSynthetic Biologics ...-0.02-1.13%
NYMXNymox Pharmaceutical...-0.02-0.58%
GLYCGlycoMimetics Inc-0.09-1.23%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
David P. Luci
Vice President-Finance &
Corporate Development
David Garrett
Corporate headquarters
New York, New York

Forecasts

Search for Jobs